Pomotrelvir (PBI-0451) is a selective, orally administered inhibitor of the SARS-CoV-2 3CL protease, exhibiting antiviral properties suitable for research into the novel coronavirus (COVID-19).
Molecular Weight:
455.94
CAS Number:
[2713437-86-4]
Formula:
C23H26ClN5O3
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted